🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesSemaglutide cardiovascular benefit independent of weight loss — March 2026 Page 4

Semaglutide cardiovascular benefit independent of weight loss — March 2026

KevinCompounds Sun, Jun 16, 2024 at 8:02 PM 50 replies 2,983 viewsPage 4 of 10
ricardo_MIA
Member
378
1,678
Sep 2024
Miami, FL
Jun 17, 2024 at 1:42 AM#16

Just wanted to say — for anyone reading this Semaglutide thread who is feeling discouraged: it gets better. The first few weeks are the hardest. Hang in there. 💪

Last edited: Jun 17, 2024 at 6:42 AM
8 1JakeSmashed95, NauseaFreeNow, SteveThurs and 5 others
Reply Quote Save Share Report
traveltech_sara
Member
156
678
Jan 2025
Remote, USA
Jun 17, 2024 at 1:59 AM#17

KevinCompounds's experience with Semaglutide resonates deeply with mine. I went through almost the identical process — starting dose, titration timeline, side effects, everything.

The main difference: I started 3 months later. But the overall trajectory has been remarkably similar. Down 50 lbs in 5 months.

One thing I would add that KevinCompounds did not mention: the mental health improvements were just as significant.

Last edited: Jun 17, 2024 at 4:59 AM
1 8LarryQC_SD
Reply Quote Save Share Report
Dr.SportsMedIN
Senior Member
1,456
6,789
Feb 2024
Indianapolis, IN
Jun 17, 2024 at 2:16 AM#18

Saving this for reference. Top-tier content.

23 6adam_van, Dr.SurgeonPGH, rachel_ABQ and 20 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides
Dr.SleepRoch
Senior Member
1,123
5,678
Apr 2024
Rochester, MN
Jun 17, 2024 at 2:33 AM#19

As a pharmacist, I want to add some clinical context to this discussion on Semaglutide cardiovascular benefit.

Building on what KevinCompounds said — the evidence base here is robust. The key publications to reference are from the SUSTAIN program[1].

Key clinical points:

  1. Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
  2. Side effect profile is predictable and usually manageable with standard protocols
  3. Monitoring should include baseline labs and follow-up at 3-month intervals
  4. Patient education significantly improves outcomes and adherence

Standard disclaimer: this is educational, not individualized medical advice.

References:
[1] See thread title for relevant study identification.
40 19tony_orlando, Dr.NephBHM_UK, kim_atl_prep and 37 others
Reply Quote Save Share Report
COA_Karl
Senior Member
2,123
8,901
Jan 2024
Pennsylvania
Jun 17, 2024 at 2:50 AM#20

Subscribing to this thread. Semaglutide is exactly what I've been researching. 🙏

38 20LindaRN_retired, tommy_boulder, hyun_seoul and 35 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register